126 related articles for article (PubMed ID: 30972956)
21. Staphylokinase-annexin XI chimera exhibited efficient in vitro thrombolytic activities.
Chiou JF; Woon MD; Cheng SN; Hsu CH; Cherng SC; Hsieh FK; Lin SM; Shiau CY
Biosci Biotechnol Biochem; 2007 May; 71(5):1122-9. PubMed ID: 17485856
[TBL] [Abstract][Full Text] [Related]
22. Integration of VEK-30 peptide enhances fibrinolytic properties of staphylokinase.
Bhando T; Singh S; Hade MD; Kaur J; Dikshit KL
Biotechnol Appl Biochem; 2021 Apr; 68(2):213-220. PubMed ID: 32233032
[TBL] [Abstract][Full Text] [Related]
23. Construction of a novel Staphylokinase (SAK) mutant with low immunogenicity and its evaluation in rhesus monkey.
Wang M; Chen Y; Fu W; Zou M; Wang Y; Xing W; Wang J; Xu D
Int J Biol Macromol; 2020 Mar; 146():781-789. PubMed ID: 31730959
[TBL] [Abstract][Full Text] [Related]
24. Cloning and purification of an anti-thrombotic, chimeric Staphylokinase in Pichia pastoris.
Vandana ; Kantipudi S; Maheshwari N; Sharma S; Sahni G
Protein Expr Purif; 2019 Oct; 162():1-8. PubMed ID: 31108209
[TBL] [Abstract][Full Text] [Related]
25. Platelet Membrane-Coated r-SAK Improves Thrombolytic Efficacy by Targeting Thrombus.
Hua R; Li M; Lin Q; Dong M; Gong X; Lin Z; Li Y; Li C; Wu T; Tan C; Zhang W; Wang Q; Wu T; Zhou X; Yang F; Li C
ACS Appl Mater Interfaces; 2024 May; 16(17):21438-21449. PubMed ID: 38626407
[TBL] [Abstract][Full Text] [Related]
26. Expression of recombinant staphylokinase in the methylotrophic yeast Hansenula polymorpha.
Moussa M; Ibrahim M; El Ghazaly M; Rohde J; Gnoth S; Anton A; Kensy F; Mueller F
BMC Biotechnol; 2012 Dec; 12():96. PubMed ID: 23253823
[TBL] [Abstract][Full Text] [Related]
27. Staphylokinase as a plasminogen activator component in recombinant fusion proteins.
Szarka SJ; Sihota EG; Habibi HR; Wong S
Appl Environ Microbiol; 1999 Feb; 65(2):506-13. PubMed ID: 9925575
[TBL] [Abstract][Full Text] [Related]
28. Lipid modification of staphylokinase and its implications on stability and activity.
Mannully ST; Shanthi C; Pulicherla KK
Int J Biol Macromol; 2019 Jan; 121():1037-1045. PubMed ID: 30342946
[TBL] [Abstract][Full Text] [Related]
29. [Preparation and activity analysis of RGD-mSAK (K130T, K135R)].
Ning BA; Ma R; Zheng YL; Gao ZX; Shen B; Jiang YQ
Sheng Wu Gong Cheng Xue Bao; 2005 May; 21(3):456-60. PubMed ID: 16108374
[TBL] [Abstract][Full Text] [Related]
30. Effect of site-specific PEGylation on the fibrinolytic activity, immunogenicity, and pharmacokinetics of staphylokinase.
Liu J; Wang Z; He J; Wang G; Zhang R; Zhao B
Acta Biochim Biophys Sin (Shanghai); 2014 Sep; 46(9):782-91. PubMed ID: 25098624
[TBL] [Abstract][Full Text] [Related]
31. Sulfotyrosine-Mediated Recognition of Human Thrombin by a Tsetse Fly Anticoagulant Mimics Physiological Substrates.
Calisto BM; Ripoll-Rozada J; Dowman LJ; Franck C; Agten SM; Parker BL; Veloso RC; Vale N; Gomes P; de Sanctis D; Payne RJ; Pereira PJB
Cell Chem Biol; 2021 Jan; 28(1):26-33.e8. PubMed ID: 33096052
[TBL] [Abstract][Full Text] [Related]
32. Functional properties of recombinant staphylokinase variants obtained by site-specific mutagenesis of methionine-26.
Schlott B; Hartmann M; Gührs KH; Birch-Hirschfeld E; Gase A; Vettermann S; Collen D; Lijnen HR
Biochim Biophys Acta; 1994 Feb; 1204(2):235-42. PubMed ID: 8142464
[TBL] [Abstract][Full Text] [Related]
33. Chimeric fibrolase: covalent attachment of an RGD-like peptide to create a potentially more effective thrombolytic agent.
Sanchez EF; Bush LR; Swenson S; Markland FS
Thromb Res; 1997 Aug; 87(3):289-302. PubMed ID: 9263396
[TBL] [Abstract][Full Text] [Related]
34. Construction and characterization of novel staphylokinase variants with antiplatelet aggregation activity and reduced immunogenecity.
Su HB; Zhang YG; He JT; Mo W; Zhang YL; Tao XM; Song HY
Acta Biochim Biophys Sin (Shanghai); 2004 May; 36(5):336-42. PubMed ID: 15156275
[TBL] [Abstract][Full Text] [Related]
35. Novel self-cleavage activity of Staphylokinase fusion proteins: An interesting finding and its possible applications.
Prasad B; Salunkhe SS; Padmanabhan S
Protein Expr Purif; 2010 Feb; 69(2):191-7. PubMed ID: 19638310
[TBL] [Abstract][Full Text] [Related]
36. Construction of novel bifunctional chimeric proteins possessing antitumor and thrombolytic activities.
Hui J; Dai Y; Bian Y; Li H; Cui X; Yu X; You S; Hu F
J Microbiol Biotechnol; 2012 Jul; 22(7):894-901. PubMed ID: 22580307
[TBL] [Abstract][Full Text] [Related]
37. Staphylokinase Enzyme: An Overview of Structure, Function and Engineered Forms.
Vakili B; Nezafat N; Negahdaripour M; Yari M; Zare B; Ghasemi Y
Curr Pharm Biotechnol; 2017; 18(13):1026-1037. PubMed ID: 29424308
[TBL] [Abstract][Full Text] [Related]
38. Structure-based antigenic epitope and PEGylation improve the efficacy of staphylokinase.
Xu Y; Shi Y; Zhou J; Yang W; Bai L; Wang S; Jin X; Niu Q; Huang A; Wang D
Microb Cell Fact; 2017 Nov; 16(1):197. PubMed ID: 29137636
[TBL] [Abstract][Full Text] [Related]
39. [Prokaryotic expression, purification and identification of recombinant staphylokinase-HC fusion protein].
Chen J; Yang K; Guo Z; Zhang YL; Zhang SC; Yang W; Zhao SS; He Q; Wang DQ; Zhou JZ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1208-11. PubMed ID: 23127416
[TBL] [Abstract][Full Text] [Related]
40. Construction of novel chimeric proteins through the truncation of SEC2 and Sak from Staphylococcus aureus.
Hui J; Yu XJ; Cui XJ; Mu T; Lin JS; Ni P; Li H; You S; Hu FQ
Biosci Biotechnol Biochem; 2014; 78(9):1514-21. PubMed ID: 25209498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
